/KASE, November 13, 2017/ – Chimpharm (Shymkent), whose shares are officially listed on Kazakhstan Stock Exchange (KASE), has notified KASE of a KZT5,022,340.37 loan received on November 8, 2017 (in Kazakh and Russian) – see more

[2017-11-13]